Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach

In recent years, advances in knowledge of molecular mechanisms involved in asthma have changed uncontrolled severe asthma (USA) treatment, with the appearance of biological treatment. USA is a heterogeneous entity with different endotypes and phenotypes. Nowadays, the biological drugs approved with...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Viña, Antolín, Díaz Campos, Rocío M., Trisan Alonso, Andrea, Melero Moreno, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701749/
https://www.ncbi.nlm.nih.gov/pubmed/36452259
http://dx.doi.org/10.3389/falgy.2022.1007593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701749/
https://www.ncbi.nlm.nih.gov/pubmed/36452259
http://dx.doi.org/10.3389/falgy.2022.1007593

Ejemplares similares